A review of 62 cases of esophageal involvement by secondary neoplasms is reported. The common routes of esophageal involvement are by direct extension of the tumor from the contiguous or adjacent organs (45.2%), via mediastinal nodes (35.5%), and hematogenous spread from a distant primary (19.3%). In the first 2 modes of esophageal involvement, the diagnosis is usually obvious but hematogenous metastases to the esophagus usually pose a diagnostic challenge. Radiologically, hematogenous metastases show a spectrum of features consisting of a short segment of progressive stricture with normal to minimally irregular mucosa, a submucosal mass with or without ulceration, a polypoid mass or masses, and defects in esophageal motility including secondary achalasia. Since endoscopy and biopsy have limited diagnostic yield, radiologic diagnosis plays a key role in the diagnosis of secondary neoplasms of the esophagus irrespective of their mode of spread to the esophagus.
Materials and Methods
Between January, 1980, and December, 1985, 62 patients with metastatic esophageal involvement were identified by the medical information and tumor registry department at the University of Michigan Medical Center, Ann Arbor. The medical records, radiographic studies, and available pathologic material, including autopsy reports, were reviewed. Esophageal involvement by direct spread occurred in 28 patients (45.2%), via mediastinal nodal spread in 22 patients (35.5%), and by hematogenous spread in 12 patients (19.3%). This information was derived after careful analysis of all clinical, radiologic, pathologic, and autopsy data.
To determine the frequency of esophageal secondary neoplasms, a comprehensive data search for total numbers of cases of cancers of the stomach, hypopharynx, larynx, lung, breast, and thyroid during the same time period (1980) (1981) (1982) (1983) (1984) (1985) was conducted and cross-referenced with cases of esophageal metastatic involvement. This information is summarized in Table 1 .
The diagnosis of secondary neoplasms of the esophagus was established by endoscopic biopsy in 33 patients, by mediastinal biopsy in 14, and by autopsy in 15. Of 50 patients who underwent endoscopy and biopsy, 28 had positive biopsies for malignancy. Among 12 patients with hematogenous metastasis who underwent endoscopic biopsies, only 3 had positive biopsies for tumor.
Fifty patients had barium esophagrams. Of these, 25 had single-contrast and 25 had double-contrast studies. Twelve patients had multiple serial esophagrams. Twenty patients had computed tomograms of the chest and abdomen. A long vertical linear ulceration is present (arrows). 
Results

Clinical Features
T h e r e were 40 m e n a n d 22 w o m e n , aged 33-78 years, with a m e d i a n age o f 59 years. T h e p r i m a r y m a l i g n a n t t u m o r s were located in the s t o m a c h (21 patients), lung (23) , breast (6), t h y r o i d (4), larynx (2), h y p o p h a r y n x (2), a n d colon, cervix, urin a r y bladder, a n d p r o s t a t e (I each). H e m a t o g en o u s spread to the e s o p h a g u s was infrequent. Pri- mary cancers of the breast, thyroid, cervix, bladder, and prostate were responsible for hematogenous metastases to the esophagus. Fifty percent of the patients complained of progressive dysphagia for 2-4 months. Three patients with lung cancer had odynophagia. The second most common complaint was weight loss of 6.8-18.2 kg. Three patients had hemoptysis, 2 had hematemesis, and I had melena.
Radiologic Features
Patients with esophageal involvement by contiguous tumors showed typical malignant radiologic features indistinguishable from those of a primary esophageal carcinoma. However, the adjacent primary tumor, such as those in the gastric cardia, hypopharynx, and larynx, was obvious and the diagnosis posed no problem. Esophageal involvement from the mediastinal lymph nodes caused nodular indentation, displacement, and compression of the esophagus initially. With progressive nodal enlargement, erosion and even mucosal ulceration of the esophagus were seen (Fig. 1) . With circumferential involvement of the esophagus, progressive luminal narrowing and stricture formation occur (Fig. 2 ). This route of spread was commonly seen in lung and breast cancer cases. Four patients developed esophagobronchial or esophagopulmonary fistulae (Fig. 3) . A secondary form of achalasia was noted in 5 patients; 4 had primary gastric cardiac carcinoma and I had metastatic colon carcinoma to the gastroesophageal region (Fig. 4) .
The most salient feature of hematogenous metastases to the esophagus was a short, progressive stricture (2.5-3 cm) with a slightly irregular mucosal contour and no mucosal ulceration (8 patients) (Fig. 5 ). The stricture was often eccentrically located (3 patients). Occasionally, longer strictures (4-6 cm) were seen (2 patients) (Fig. 6) . A submucosal mass was noted in I patient (Fig. 7) . One patient developed severe esophageal dysmotility due to metastases involving the myenteric plexus from carcinoma of the prostate. Review of the computed tomographic studies available in 20 patients revealed esophageal wall thickening in 6 (Fig. 2B) , mediastinal mass in 3, and an esophagopulmonary fistula with a pulmonary necrotic mass in 1 (Fig. 3 B) .
The radiologic diagnosis of esophageal involvement was accurately suggested in 25 of 28 patients (89.3%) with direct spread, 16 of 22patients (72.7%) with mediastinal spread, and 8 of 12 patients (68.2%) with hematogenous spread. The overall accurate diagnosis was suggested in 78% of patients.
Discussion
Esophageal involvement by metastatic tumors may occur by direct tumor extension from contiguous organs, through mediastinal lymph nodes containing tumor, and via hematogenous spread [4] . The first of these is the most common and is usually seen with tumors of the gastric fundus, hypopharynx, and larynx [2] . Contiguous spread of tumor to the distal esophagus from carcinoma of the stomach is well known [5] [6] [7] and it is common for carcinoma of the gastric cardia to present with esophageal symptoms initially. Direct esophageal extension of an adjacent tumor usually occurs by lymphatic spread within the esophageal wall through a subepithelial lymphatic plexus in the mucosa that anastomoses freely with another plexus in the submucosa, muscularis, and adventitia [8] . Carcinoma of the hypopharynx and larynx may extend to the cervical esophagus in a similar fashion. In most instances when the esophagus is involved by direct tumor extension, the primary site is apparent [2, 9, 10] .
Involvement of the esophagus by tumor-containing mediastinal lymph nodes is the second most common route of esophageal invasion by metastatic tumors. Autopsy reports have shown that 4% of patients with carcinoma of the lung [11] and 9% of those with breast carcinoma [12] had metastatic esophageal tumor. Although lung and breast carcinomas are the sources of most of the tumors, any metastatic mediastinal tumor may invade the esophagus secondarily [13] [14] [15] [16] [17] . Generally, metastatic esophageal involvement by tumors located below the diaphragm occurs via mediastinal spread and sometimes by direct extension to the abdominal segment of the esophagus, as in the case of pancreatic carcinoma [15] .
Hematogenous metastases to the esophagus are rare and may occur from cancers of the pancreas, testis, eye, tongue, bone, liver, kidney, uterus, skin, synovium, and prostate [3, [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . The present study adds cancers of the cervix, urinary bladder, and breast to this list. Metastatic melanoma [26] [27] [28] and lymphoma [29] involving the esophagus secondarily have also been reported.
In a review by Garusi and Donati [30] of 82 instances of metastasis to the esophagus, the breast was the proven source in 28 cases, the pharynx in 26, the stomach in 10, and the lungs in 3, with a wide variety of other sources causing the remainder.
Excluding gastric carcinoma, involvement of the esophagus by metastases from malignant tumors of other organs is infrequent. Torensen [1] reviewed 26 patients in whom the esophagus was involved by metastatic tumors; the primary sites were trachea or bronchus in 8, stomach in 7, larynx 4, breast 2, pancreas 2, testis 1, mediastinal nodes 1, and an unknown location in 1. His 3.2% incidence of esophageal involvement by metastatic tumor was derived from a large autopsy series. Sanborn et al. [13] , analyzing neoplasms metastasizing to the mediastinum, found that carcinomas of the breast, lung, esophagus, and stomach predominated, but primary tumors of every organ were encountered. They concluded that virtually any malignant tumor might metastasize to the mediastinal lymph nodes. Thus any such tumor involvement of the mediastinal nodes may also involve the esophagus.
The majority of patients with primary esophageal carcinoma present with a clinical picture including dysphagia, regurgitation, substernal distress, and weight loss, and show characteristic radiologic features [6, 7, 31] . With the exception of gastric carcinoma, metastases to the esophagus infrequently produce symptoms. There are very few early signs of invasion of the esophageal wall from without and of metastatic intramural growth. Dysphagia may be a patient's first symptom of metastatic carcinoma of pulmonary origin [9, 10, 32] . Occasionally, dysphagia may be a presenting symptom in tumors of nonpulmonary origin [3, 4, 19, 33] . Usually, dysphagia develops a conSiderable time after the site of the primary tumor has been established. In cases of carcinoma of the breast, dysphagia develops many years after mastectomy, A review of 44 cases revealed that the mean interval from mastectomy to the recording of dysphagia was 7.1 _ 4.2 years (SD) with a peak incidence at 4~5 years [12, 17, 18] . By the time dysphagia develops, indicating significant esophageal involvement, the breast Carcinoma is usually widespread. In the present study the dysphagia occurred approximately 4 years after initial detection of the breast carcinoma.
The radiologic features of a secondary esophageal tumor are clearly dependent upon its route of spread to the esophagus. The tumors of a contiguous organ directly spreading to the esophagus show typical changes of malignant tumor involvement that are at times indistinguishable from a primary esophageal carcinoma. However, the obvious primary tumors in the contiguous organ pose no problem in establishing the diagnosis. The tumors spreading via mediastinal nodes and secondarily invading the esophagus show nodular indentation, compression, deviation, rigid segmental narrowing, and even ulceration of the esophagus.
Hematogenous metastases to the esophagus usually pose a diagnostic challenge and commonly present as a short esophageal stricture with normal or minimally irregular mucosa. Occasionally, long segments of involvement may occur. Such strictures may taper asymmetrically and may be con-fused with benign peptic strictures. The shorter stricture involving the middle third of the esophagus should be differentiated from Barrett's stricture. A history of gastroesophageal reflux, hiatal hernia, and other supporting features of Barrett's esophagus are usually helpful in this differentiation [34] . When only 1 wall of the esophagus is involved by the metastatic tumor, it may simulate mediastinal lymphadenopathy or other benign mediastinal masses. A metastatic submucosal tumor mass may simulate a benign submucosal lesion such as leiomyoma. When the tumor infiltration progresses and involves the esophagus circumferentially, it may simulate a primary esophageal carcinoma [3, 14, 23, 24] .
The phenomenon of esophageal dysmotility and aperistalsis, as observed in 1 of our patients, had been previously reported by Simeone et al. [35] . Although they proposed that metastatic tumor involvement of the myenteric plexus was responsible for esophageal dysmotility in their patient and seems to be the case in some cases, this explanation of esophageal motor dysfunction has not yet been completely accepted and established by other investigators [36] . In our patient, metastatic tumor was found involving the myenteric plexus of the esophagus at autopsy. A secondary form of achalasia, clinically indistinguishable from the primary idiopathic form, has been reported in tumors of the gastric cardia and a variety of other neoplasms involving the distal esophagus [37] [38] [39] . We have previously reported an incidence of secondary achalasia of 20-25% in gastric cardiac carcinoma, 3% in primary squamous cell carcinoma of the distal esophagus, and 8% in Barrett's-type adenocarcinoma of the esophagus [7] . The 5 cases of secondary achalasia in the present series were due to primary tumor of the gastric cardia in 4 and ~o colonic cancer metastasis to the gastroesophageal region in 1.
Varicoid appearance due to a submucosal metastatic lesion from prostate carcinoma has been recently reported [17] . This appearance, though commonly seen in primary esophageal malignant tumors (Barrett's-type adenocarcinoma 40% and squamous cell carcinoma 5%) [7, 35] , was not seen in any of our patients with secondary esophageal neoplasms. Most malignant polypoid tumors of the esophagus are usually spindle cell squamous carcinoma or sarcoma [40] . Metastatic melanoma presenting as large polypoid intraluminal mass in the esophagus has been reported [26] [27] [28] .
In evaluating the efficacy of single-versus double-contrast studies, we have found no appreciable difference in their diagnostic yield. The mucosal detail was unquestionably superior with double contrast studies. Computed tomography (CT) was useful in the evaluation of the esophageal wall thickening, and extraesophageal, mediastinal, pulmonary, and chest wall abnormalities. However, in suggesting the diagnosis of secondary neoplasm of the esophagus, CT was of limited value.
Endoscopy and biopsy specimens of metastatic esophageal tumors usually show normal or inflamed mucosa and are reported to be positive for tumor in only 50% of cases [9, 15, 17, 22, [41] [42] [43] . Because of the increased incidence of esophageal perforation, some authors do not advocate these procedures for patients with a history of breast carcinoma who present with esophageal symptoms and show radiographic evidence of esophageal involvement [43] . They recommend treating these patients empirically with radiation therapy.
In summary, a comprehensive clinical and radiologic review of 62 pathologically proven cases of secondary neoplasms of the esophagus is reported. This information should further assist clinicians in correctly diagnosing metastatic esophageal tumor and therefore improve patient management [44] [45] .
